Natural History Study of Mitochondrial Myopathy

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Children's Hospital of Philadelphia
Study ID
NCT05250375
Status
Recruiting

Conditions

  • Primary Mitochondrial Disease

Eligibility Criteria

Sex
ALL
Age
0 Years - 100 Years
Healthy Volunteers
Accepted

Study Details

The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are: * Development, validation, and optimization of objective outcome measures for mitochondrial myopathy * Defining the natural history of mitochondrial myopathy Researchers will compare data from patients with primary mitochondrial myopathy to healthy controls. Data from healthy controls will also help define normative data for future studies. Participants will perform clinical exams of muscle strength and endurance and will complete surveys.

Key Dates

Start date
Mar 24, 2017
Status verified
Sep 2025
Primary completion
Mar 24, 2030
Completion
Mar 24, 2030

Study Design

Enrollment
1,300 participants (estimated)

Arms

  • Arm: Primary Mitochondrial Myopathy
    Patients with a mitochondrial disorder established by confirmed genetic or biochemical mutation in mtDNA or nuclear DNA or is suitable for participation in the opinion of the investigator based on clinical presentation and exhibits myopathy (exercise intolerance, muscle strength, fatigue) relating to mitochondrial disease.
  • Arm: Healthy Controls
    Males or females age 0-100 years of age with no history of mitochondrial myopathy symptoms.

Primary Outcome Measure

Muscle Strength of MM-COAST [ Time Frame: through study completion, an average of 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104
Amanda Wellik
267-426-4961

Find similar trials in Philadelphia, PA

Related Studies